2013
DOI: 10.3892/ijo.2013.1813
|View full text |Cite
|
Sign up to set email alerts
|

Cyclin-dependent kinase 2-associated protein 1 suppresses growth and tumorigenesis of lung cancer

Abstract: Cyclin-dependent kinase 2-associated protein 1 (CDK2AP1), a growth suppressor that negatively regulates CDK2 activity, has been implicated in various types of cancer; yet its role in lung cancer remains unclear. In the present study, a lentivirus-based system was used to specifically downregulate or upregulate CDK2AP1 expression. A549 lung cancer cells were treated with RNAi (RNA interference) or lentiviral vectors for overexpression. Ectopic overexpression of CDK2AP1 in A549 cells in vitro greatly impaired th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
9
1

Year Published

2013
2013
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 24 publications
1
9
1
Order By: Relevance
“…Recently, several studies have reported negative or decreased DOC‐1 expression in gastric cancer tissue, and this was highly correlated with more advanced tumor stage and invasion [], risk of lymph node metastases, and decreased survival in patients with OSCC []. Similar reports were observed from many cancer types including prostate cancer [], esophageal carcinoma [], breast cancer [], colorectal cancer [], and lung cancer [].…”
Section: Introductionsupporting
confidence: 83%
See 1 more Smart Citation
“…Recently, several studies have reported negative or decreased DOC‐1 expression in gastric cancer tissue, and this was highly correlated with more advanced tumor stage and invasion [], risk of lymph node metastases, and decreased survival in patients with OSCC []. Similar reports were observed from many cancer types including prostate cancer [], esophageal carcinoma [], breast cancer [], colorectal cancer [], and lung cancer [].…”
Section: Introductionsupporting
confidence: 83%
“…In the present study, we reported the differential mRNA expression of the tumor suppressor deleted in oral cancer‐1 (DOC‐1) gene, which has not been reported previously in relation to the precancerous conditions of OSF, OLP, and LKP, and differential oral habits. Clinically, a decrease in DOC‐1 expression in OSCC and other forms of cancers has been found to correlate with its potential role in malignancy [], whereas in vivo studies have shown that the overexpression of DOC‐1 in mouse and hamster model of OC, and HCPC‐1 cells significantly induced antitumor response, growth suppression, and an increase in apoptosis and antiproliferative effect [,]. In the present study, a loss of DOC‐1 mRNA expression was observed in 61% of patients with OSCC and a reduced DOC‐1 mRNA expression in 39% of patients.…”
Section: Discussionmentioning
confidence: 45%
“…A link between altered CDK1 expression and PE has not been previously reported. Vannucci et al [16] described up-regulation of CDK2-associated protein 1 (CDK2AP1), a growth suppressor that down-regulates CDK2 [46]. Since CDK2 has an effect on the cell cycle that is broadly similar to CDK1, it seems counter-intuitive that a CDK2 suppressor protein is up-regulated in PE.…”
Section: Discussionmentioning
confidence: 99%
“…Cyclin-dependent kinase 2-associated protein 1 (CDK2AP1), also named as DOC-1 (deleted in oral cancer-1), is a growth suppressor originally isolated from normal hamster oral keratinocytes [ 20 ]. There is evidence to suggest that CDK2AP1, as an inhibitor of CDK2 and hence G1/S transition, is expected to involve cell cycle progression [ 21 ]. In addition, recent studies showed that CDK2AP1 mediates the growth suppressing signal from TGF-β [ 22 ].…”
Section: Introductionmentioning
confidence: 99%